RT Journal Article
SR Electronic
T1 Update on the management of venous thromboembolism
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 39
OP 46
DO 10.3949/ccjm.84.s3.04
VO 84
IS 12 suppl 3
A1 John R. Bartholomew
YR 2017
UL http://www.ccjm.org/content/84/12_suppl_3/39.abstract
AB Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, is a common cardiovascular disease associated with significant morbidity ranging from painful leg swelling, chest pain, shortness of breath, and even death. Long-term complications include recurrent VTE, postpulmonary embolism syndrome, chronic thromboembolic pulmonary hypertension, and postthrombotic syndrome (PTS). Management of VTE requires immediate anticoagulation therapy based on a risk assessment for bleeding. Direct oral anticoagulants (DOACs) have become an important option for patients as reflected in the most recent American College of Chest Physician treatment guidelines.